Encompass Health Corp (NYSE:EHC) Receives Average Rating of “Buy” from Brokerages

Shares of Encompass Health Corp (NYSE:EHC) have received a consensus recommendation of “Buy” from the eight analysts that are covering the company, Marketbeat reports. Two equities research analysts have rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average 1 year price target among brokers that have issued a report on the stock in the last year is $74.60.

Several analysts recently commented on the company. Deutsche Bank assumed coverage on Encompass Health in a research report on Tuesday, September 17th. They issued a “hold” rating and a $70.00 target price on the stock. Raymond James lowered their target price on Encompass Health from $80.00 to $75.00 and set an “outperform” rating on the stock in a research report on Wednesday, July 31st. ValuEngine cut Encompass Health from a “buy” rating to a “hold” rating in a research report on Wednesday, October 30th. Finally, Bank of America upgraded Encompass Health to a “buy” rating in a research report on Friday, September 6th.

Shares of Encompass Health stock opened at $70.41 on Friday. The company has a current ratio of 0.97, a quick ratio of 0.97 and a debt-to-equity ratio of 1.94. The business’s 50 day simple moving average is $65.15 and its 200-day simple moving average is $63.02. The stock has a market capitalization of $6.81 billion, a price-to-earnings ratio of 19.40, a PEG ratio of 2.02 and a beta of 0.82. Encompass Health has a twelve month low of $56.74 and a twelve month high of $76.20.

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Investors of record on Thursday, January 2nd will be given a $0.28 dividend. This represents a $1.12 annualized dividend and a yield of 1.59%. The ex-dividend date of this dividend is Tuesday, December 31st. Encompass Health’s dividend payout ratio is currently 30.85%.

Encompass Health Company Profile

Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.

See Also: Futures Contract

Analyst Recommendations for Encompass Health (NYSE:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.